Global Interferon Alpha-2a Biosimilar Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

REPORT SUMMARY
TABLE OF CONTENTS

Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent. An oral form is being developed by Amarillo Biosciences.

The global average price of Interferon Alpha-2a Biosimilar is in the decreasing trend, from 186.78 USD/Unit in 2013 to 64.67 USD/Unit in 2017. With the situation of global economy, prices will be in decreasing trend in the following five years.The classification of Interferon Alpha-2a Biosimilar includes ordinary type and long-lasting type, and the proportion of ordinary type in 2017 is about 64%, and the proportion is in increasing trend from 2013 to 2017.Interferon Alpha-2a Biosimilar is widely used for hepatitis C, hepatitis B and other diseases. The most proportion of Interferon Alpha-2a Biosimilar is used for hepatitis C, and the proportion in 2017 is 46%. Europe is the largest supplier of Interferon Alpha-2a Biosimilar, with a production market share nearly 70% in 2017. South America is the largest consumption place, with a consumption market share nearly 26% in 2017. Following South America, Europe is the second largest consumption place with the consumption market share of 22%. Market competition is not intense. Amega Biotech, PROBIOMED, Roche, Rhein Minapharm Biogenetics, 3sbio, Nanogen, Zydus Cadila, Biosidus, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

Interferon Alpha-2a Biosimilar market report explains the definition, types, applications, major countries, and major players of the Interferon Alpha-2a Biosimilar market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

The report contains qualitative and quantitative analysis of the entire industry.

The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

By Player:
- Amega Biotech
- PROBIOMED
- Roche
- Rhein Minapharm Biogenetics
- 3sbio
- Nanogen
- Zydus Cadila
- Biosidus
By Type:
- Long-lasting Type
- Ordinary Type
By End-User:
- Hepatitis C
- Hepatitis B
- Other
By Region:

North America
- United States
- Canada
- Mexico
Europe
- Germany
- UK
- Spain
- France
- Italy
- Denmark
- Finland
- Norway
- Sweden
- Poland
- Russia
- Turkey
Asia-Pacific
- China
- Japan
- India
- South Korea
- Pakistan
- Bangladesh
- Indonesia
- Thailand
- Singapore
- Malaysia
- Philippines
- Vietnam
- Others
South America
- Brazil
- Colombia
- Chile
- Argentina
- Venezuela
- Peru
- Puerto Rico
- Ecuador
- Others
GCC
- Bahrain
- Kuwait
- Oman
- Qatar
- Saudi Arabia
- United Arab Emirates
Africa
- Nigeria
- South Africa
- Egypt
- Algeriat
- Others
Oceania
- Australia
- New Zealand
TABLE OF CONTENT
1. Global Interferon Alpha-2a Biosimilar Executive Summary
- 1.1 Introduction
- 1.2 Market Panorama, 2022
2 Coronavirus Impact
- 2.1 Interferon Alpha-2a Biosimilar Outlook to 2028- Original Forecasts
- 2.2 Interferon Alpha-2a Biosimilar Outlook to 2028- COVID-19 Affected Forecasts
- 2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
- 3.1 Potential Market Drivers and Opportunities
- 3.2 New Challenges and Strategies
- 3.3 Short Term and Long Term Interferon Alpha-2a Biosimilar Market Trends
4 Key Inferences
5 Market Overview
- 5.1 Current Market Scenario
- 5.2 Porter's Five Forces Analysis
6 Global Interferon Alpha-2a Biosimilar Market- Recent Developments
- 6.1 Interferon Alpha-2a Biosimilar Market News and Developments
- 6.2 Interferon Alpha-2a Biosimilar Market Deals Landscape
7 Interferon Alpha-2a Biosimilar Raw Materials and Cost Structure Analysis
- 7.1 Interferon Alpha-2a Biosimilar Key Raw Materials
- 7.2 Interferon Alpha-2a Biosimilar Price Trend of Key Raw Materials
- 7.3 Interferon Alpha-2a Biosimilar Key Suppliers of Raw Materials
- 7.4 Interferon Alpha-2a Biosimilar Market Concentration Rate of Raw Materials
- 7.5 Interferon Alpha-2a Biosimilar Cost Structure Analysis
8 Global Interferon Alpha-2a Biosimilar Import and Export Analysis (Top 10 Countries)
- 8.1 Global Interferon Alpha-2a Biosimilar Import by Region (Top 10 Countries) (2017-2028)
- 8.2 Global Interferon Alpha-2a Biosimilar Export by Region (Top 10 Countries) (2017-2028)
9 Global Interferon Alpha-2a Biosimilar Market Outlook by Types and Applications to 2022
- 9.1 Global Interferon Alpha-2a Biosimilar Consumption and Growth Rate by Type (2017-2022)
- 9.2 Global Interferon Alpha-2a Biosimilar Consumption and Growth Rate by Application (2017-2022)
10 Region and Country-wise Interferon Alpha-2a Biosimilar Market Analysis and Outlook till 2022
- 10.1 Global Interferon Alpha-2a Biosimilar Consumption (2017-2022)
- 10.2 North America Consumption Analysis
- 10.3 Europe Consumption Analysis
- 10.4 APAC Consumption Analysis
- 10.5 South America Consumption Analysis
- 10.6 GCC Consumption Analysis
- 10.7 Africa Consumption Analysis
- 10.8 Oceania Consumption Analysis
11 Global Interferon Alpha-2a Biosimilar Competitive Analysis
- 11.1 Amega Biotech
- 11.2 PROBIOMED
- 11.3 Roche
- 11.4 Rhein Minapharm Biogenetics
- 11.5 3sbio
- 11.6 Nanogen
- 11.7 Zydus Cadila
- 11.8 Biosidus
12 Global Interferon Alpha-2a Biosimilar Market Outlook by Types and Applications to 2028
- 12.1 Global Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate by Type (2022-2028)
- 12.2 Global Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate by Application (2022-2028)
13 Country-wise Interferon Alpha-2a Biosimilar Market Analysis and Outlook to 2028
- 13.1 Global Interferon Alpha-2a Biosimilar Consumption Forecast (2022-2028)
- 13.2 North America Consumption Analysis
- 13.3 Europe Consumption Analysis
- 13.4 APAC Consumption Analysis
- 13.5 South America Consumption Analysis
- 13.6 GCC Consumption Analysis
- 13.7 Africa Consumption Analysis
- 13.8 Oceania Consumption Analysis
14 Conclusions
The List of Tables and Figures
- Table Definition of Interferon Alpha-2a Biosimilar
- Figure of Interferon Alpha-2a Biosimilar Picture
- Table Global Interferon Alpha-2a Biosimilar Import by Region (Top 10 Countries) (2017-2028)
- Table Global Interferon Alpha-2a Biosimilar Export by Region (Top 10 Countries) (2017-2028)
- Figure Global Long-lasting Type Consumption and Growth Rate (2017-2022)
- Figure Global Ordinary Type Consumption and Growth Rate (2017-2022)
- Figure Global Hepatitis C Consumption and Growth Rate (2017-2022)
- Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)
- Figure Global Other Consumption and Growth Rate (2017-2022)
- Figure Global Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Table North America Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Figure United States Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Canada Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Mexico Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Table Europe Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Figure Germany Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure UK Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Spain Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Belgium Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure France Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Italy Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Denmark Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Finland Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Norway Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Sweden Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Poland Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Russia Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Turkey Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Table APAC Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Figure China Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Japan Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure India Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure South Korea Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Pakistan Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Bangladesh Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Indonesia Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Thailand Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Singapore Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Malaysia Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Philippines Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Vietnam Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Table South America Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Figure Brazil Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Colombia Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Chile Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Argentina Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Venezuela Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Peru Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Puerto Rico Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Ecuador Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Table GCC Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Figure Bahrain Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Kuwait Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Oman Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Qatar Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Saudi Arabia Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure United Arab Emirates Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Table Africa Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Figure Nigeria Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure South Africa Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Egypt Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure Algeria Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Table Oceania Interferon Alpha-2a Biosimilar Consumption by Country (2017-2022)
- Figure Australia Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Figure New Zealand Interferon Alpha-2a Biosimilar Consumption and Growth Rate (2017-2022)
- Table Amega Biotech Company Details
- Table Amega Biotech Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table Amega Biotech Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table Amega Biotech Interferon Alpha-2a Biosimilar Product Portfolio
- Table PROBIOMED Company Details
- Table PROBIOMED Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table PROBIOMED Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table PROBIOMED Interferon Alpha-2a Biosimilar Product Portfolio
- Table Roche Company Details
- Table Roche Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table Roche Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table Roche Interferon Alpha-2a Biosimilar Product Portfolio
- Table Rhein Minapharm Biogenetics Company Details
- Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table Rhein Minapharm Biogenetics Interferon Alpha-2a Biosimilar Product Portfolio
- Table 3sbio Company Details
- Table 3sbio Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table 3sbio Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table 3sbio Interferon Alpha-2a Biosimilar Product Portfolio
- Table Nanogen Company Details
- Table Nanogen Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table Nanogen Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table Nanogen Interferon Alpha-2a Biosimilar Product Portfolio
- Table Zydus Cadila Company Details
- Table Zydus Cadila Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table Zydus Cadila Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table Zydus Cadila Interferon Alpha-2a Biosimilar Product Portfolio
- Table Biosidus Company Details
- Table Biosidus Interferon Alpha-2a Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
- Table Biosidus Interferon Alpha-2a Biosimilar Main Business and Markets Served
- Table Biosidus Interferon Alpha-2a Biosimilar Product Portfolio
- Figure Global Long-lasting Type Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Ordinary Type Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
- Figure Global Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Table North America Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Figure United States Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Canada Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Mexico Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Table Europe Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Figure Germany Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure UK Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Spain Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Belgium Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure France Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Italy Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Denmark Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Finland Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Norway Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Sweden Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Poland Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Russia Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Turkey Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Table APAC Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Figure China Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Japan Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure India Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure South Korea Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Pakistan Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Bangladesh Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Indonesia Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Thailand Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Singapore Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Malaysia Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Philippines Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Vietnam Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Table South America Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Figure Brazil Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Colombia Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Chile Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Argentina Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Venezuela Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Peru Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Puerto Rico Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Ecuador Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Table GCC Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Figure Bahrain Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Kuwait Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Oman Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Qatar Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Saudi Arabia Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure United Arab Emirates Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Table Africa Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Figure Nigeria Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure South Africa Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Egypt Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure Algeria Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Table Oceania Interferon Alpha-2a Biosimilar Consumption Forecast by Country (2022-2028)
- Figure Australia Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)
- Figure New Zealand Interferon Alpha-2a Biosimilar Consumption Forecast and Growth Rate (2022-2028)

Interferon Alpha-2a Biosimilar Market Report

Global Interferon Alpha-2a Biosimilar Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

1. Global Interferon Alpha-2a Biosimilar Executive Summary

2 Coronavirus Impact

3 Strategic Analytics to Boost Productivity and Profitability

4 Key Inferences

5 Market Overview

6 Global Interferon Alpha-2a Biosimilar Market- Recent Developments

7 Interferon Alpha-2a Biosimilar Raw Materials and Cost Structure Analysis

8 Global Interferon Alpha-2a Biosimilar Import and Export Analysis (Top 10 Countries)

9 Global Interferon Alpha-2a Biosimilar Market Outlook by Types and Applications to 2022

10 Region and Country-wise Interferon Alpha-2a Biosimilar Market Analysis and Outlook till 2022

11 Global Interferon Alpha-2a Biosimilar Competitive Analysis

12 Global Interferon Alpha-2a Biosimilar Market Outlook by Types and Applications to 2028

13 Country-wise Interferon Alpha-2a Biosimilar Market Analysis and Outlook to 2028

14 Conclusions

The List of Tables and Figures

Report Version Choose

Our Customers

Beyond Consulting, Future is Feasible

Quick Link

CONTACT US